![Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal Drugs | Molecular Pharmaceutics Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal Drugs | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.8b00087/asset/images/large/mp-2018-00087j_0006.jpeg)
Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal Drugs | Molecular Pharmaceutics
![Unusual Growth and Hydration Characteristics of Oil Solubilized Micelles in Aqueous Pluronic Systems | The Journal of Physical Chemistry B Unusual Growth and Hydration Characteristics of Oil Solubilized Micelles in Aqueous Pluronic Systems | The Journal of Physical Chemistry B](https://pubs.acs.org/cms/10.1021/acs.jpcb.1c04450/asset/images/large/jp1c04450_0011.jpeg)
Unusual Growth and Hydration Characteristics of Oil Solubilized Micelles in Aqueous Pluronic Systems | The Journal of Physical Chemistry B
![Pharmaceutics | Free Full-Text | Carbohydrates Used in Polymeric Systems for Drug Delivery: From Structures to Applications Pharmaceutics | Free Full-Text | Carbohydrates Used in Polymeric Systems for Drug Delivery: From Structures to Applications](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-00739/article_deploy/html/images/pharmaceutics-14-00739-g001.png)
Pharmaceutics | Free Full-Text | Carbohydrates Used in Polymeric Systems for Drug Delivery: From Structures to Applications
![Medica RCP |Unimer Pediatric Hypertonic | Indications | Side Effects | Composition | Route | all.price | Alternative Products Medica RCP |Unimer Pediatric Hypertonic | Indications | Side Effects | Composition | Route | all.price | Alternative Products](https://medicarcp.com/website/images/Products_flat/906166.jpg)
Medica RCP |Unimer Pediatric Hypertonic | Indications | Side Effects | Composition | Route | all.price | Alternative Products
![Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal Drugs | Molecular Pharmaceutics Pharmacological Characterization of the RPMI 2650 Model as a Relevant Tool for Assessing the Permeability of Intranasal Drugs | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.8b00087/asset/images/medium/mp-2018-00087j_0005.gif)